HIV Infections: all 4,342 studies
Page 17 of 44. Open to participants first (242), then studies with results posted, then the rest; newest registration first within each.
- Social Capital and Engagement in Care Among Young Black Men Who Have Sex With Men Living With HIVCompletedNCT03664817Not applicable
- HIV Infection and Risk Related Coinfections/Comorbidities in IndonesiaCompletedNCT03663920
- HIV Awal (Early) Testing & Treatment Indonesia Project Intervention PhaseCompletedNCT03659253Not applicable
- Transgender Youth and PrEP: PK, Safety, Uptake & Adherence - PK StudyCompletedNCT03652623Phase 1/2
- Decision Support Intervention Adapted for HIV Pre-Exposure Prophylaxis for Adoption and Adherence for Black CanadiansStatus unknownNCT03637244Not applicable
- Village-based vs Clinic-based ART Care - a Cluster Randomized Controlled Trial in LesothoCompletedNCT03630549Phase 4
- A Clinical Trial to Evaluate the Immunogenicity of the Nonavalent Vaccine Against Human Papillomavirus in Men Infected by HIV Who Have Sex With Men. GESIDA 10017CompletedNCT03626467Phase 4
- Role of the IL33/Amphiregulin Pathway as a Potential Therapeutic Target in HIV InfectionStatus unknownNCT03622177
- Evaluating a Combination of Immune-based Therapies to Achieve a Remission of HIV InfectionWithdrawnNCT03619278Phase 1/2
- Interventions to Improve HIV Antiretroviral Therapy AdherenceCompletedNCT03618511Not applicable
- PC4PrEP: Integrating PrEP Into Primary CareCompletedNCT03617874Not applicable
- Evaluation of Third-line cART Regimen in Cambodia (3DICAM)Status unknownNCT03602690Phase 2
- Technology Based Community Health Nursing to Improve Combination Anti-Retroviral Therapy (cART) Adherence and Virologic Suppression in Youth Living With HIVCompletedNCT03600103Not applicable
- HOme-based SElf-testiNG - a Cluster Randomized Controlled Trial in Rural Lesotho (HOSENG)CompletedNCT03598686Not applicable
- Cash Transfer to Adolescent Girls and Young Women to Reduce Sexual Risk Behavior - an Impact EvaluationStatus unknownNCT03597243Not applicable
- Transgender Cohort Study of Gender Affirmation and HIV-related HealthStatus unknownNCT03595956
- Therapeutic Drug Monitoring Study of Reduced-Dose Efavirenz (400 mg) in Combo Tablet for Patients Receiving Atripla With Viral Suppression in TaiwanCompletedNCT03595709Phase 3
- Peg-Interferon Alpha 2b Combined With Two Intravenous Broadly HIV-1 Neutralizing Antibodies 3BNC117 and 10-1074 (BEAT-2)Status unknownNCT03588715Phase 1
- Partners PrEP ProgramCompletedNCT03586128
- Youth Services Navigation Intervention for HIV+ Youth Being Released From or At-risk for IncarcerationCompletedNCT03584932Not applicable
- HIV, Buprenorphine, and the Criminal Justice System (STRIDE2)CompletedNCT03583138
- Black Men's Care, and Intervention to Re-Engage HIV+ Black Men in CareCompletedNCT03579251Not applicable
- Vedolizumab Treatment in HIV-Infected Subjects Without Previous Antiretroviral TherapyStatus unknownNCT03577782Phase 1/2
- An Italian Observation of Antiretroviral Treatment in Participants Taking Darunavir/ Cobicistat Plus Emtricitabine and Tenofovir Alafenamide FumarateCompletedNCT03577470
- Addressing Overdose Risk Among Recently Incarcerated People Living With HIV/AIDSCompletedNCT03569592Not applicable
- Manicaland VMMC Uptake Through Behavioural Incentives TrialCompletedNCT03565588Not applicable
- A Study to Determine the Safety and Efficacy of Rilpivirine in Treatment-naive Indian Participants With Human Immunodeficiency Virus Type 1 (HIV-1) InfectionTerminatedNCT03563742Phase 3
- Impact of Representative Payee Services on ART Adherence Among Marginalized People Living With HIV/AIDSCompletedNCT03561103Not applicable
- A Field Experiment to Assess the Demand for HIV Self-Tests in ZimbabweCompletedNCT03559959Not applicable
- Increasing PrEP Among African Americans in Louisville KYCompletedNCT03559595Not applicable
- Spanish Cohort of Patients with HIV Infection Older Than 50 Years for the Study of Fragility and Physical FunctionActive, not recruitingNCT03558438
- PHAT Life: Peer Versus Adult-Led HIV Prevention for Juvenile OffendersCompletedNCT03555279Not applicable
- First-in-human Study of 10-1074-LS Alone and in Combination With 3BNC117-LSCompletedNCT03554408Phase 1
- Cannabinoids in PLWHIV on Effective ARTTerminatedNCT03550352Phase 2
- Diagnostic of Human Immunodeficiency Virus (HIV) and Other Sexual Transmission Diseases (STD) in High Risk Populations: Men Who Have Sex With Men (MSM) Users of ChemsexStatus unknownNCT03546140
- A Cluster Randomised Trial of Community-led Distribution of HIV Self-tests in Rural Malawi (HIV Self-Testing Africa [STAR])CompletedNCT03541382Not applicable
- Reaching 90% HIV Suppression: The Role of POC Viral Load Monitoring in NigeriaCompletedNCT03533868Not applicable
- Project PRIDE (Promoting Resilience In Discriminatory Environments)CompletedNCT03528135Not applicable
- Improving Health Outcomes for Women Living With HIVCompletedNCT03525340Not applicable
- Pertussis Immunization During Pregnancy & HIV InfectionCompletedNCT03519373
- Evaluation of a Home-based Community Health Worker Program in Rural Eastern Cape, South AfricaCompletedNCT03517878
- An Efficacy and Safety Study of shRNA-modified CD34+ Cells in HIV-infected Patients.Status unknownNCT03517631Phase 1
- Using Social Media to Improve ART Retention and Treatment Outcomes Among YLHIV in NigeriaTerminatedNCT03516318Not applicable
- A Waiting Room-Delivered Video to Enhance Clinical Outcomes Among Persons Living With HIVCompletedNCT03508310Not applicable
- Community Home-based Care Intervention and Its Health Outcome in HIV-positive PeopleCompletedNCT03505866Not applicable
- Evaluating the Safety and Immunogenicity of the IHV01 Protein Vaccine Primed and Co-Administered With HIV DNA CON-S Env Vaccine in Healthy, HIV-1-Uninfected AdultsWithdrawnNCT03505060Phase 1
- Efficacy, Safety & Tolerability of Switching EFV/TDF/FTC to BIC/FTC/TAF in Virologically Suppressed Adults With HIV-1CompletedNCT03502005Phase 4
- Behavioral Economics Incentives to Support HIV Treatment Adherence in Sub-Saharan AfricaCompletedNCT03494777Not applicable
- The Prevention Options for Women Evaluation Research (POWER) CohortCompletedNCT03490058
- Mitochondria in HIV and Aging (MITO+)CompletedNCT03489421
- Prevalence,Knowledge and Attitude of HIV /AIDS in LuxorStatus unknownNCT03485599
- People Living With HIV/AIDS, Nitrate, Endotelial Function, Arterial Stiffness and Skeletal Muscle OxygenationCompletedNCT03485248Not applicable
- Body Compartment Pharmacokinetics of Anti- Retroviral Agents That May be Used for Future HIV Post- Exposure Prophylaxis.CompletedNCT03472963Phase 1
- 123I Radiolabeled 3BNC117CompletedNCT03468582Early Phase 1
- HIV Prevention Among Latina Transgender Women Who Have Sex With Men: Evaluation of a Locally Developed InterventionCompletedNCT03465852Not applicable
- Access to PrEP for MSM: Acceptability and Feasibility in Community-based Clinics in West Africa (CohMSM-PrEP)CompletedNCT03459157Not applicable
- Tripe Versus Dual Antiretroviral Therapy in HIV-infected Patients With Virological Suppression (Tridual)CompletedNCT03447873Phase 4
- Quality of Life, Sleep, and Biomarkers in People With HIV/AIDSCompletedNCT03445351Not applicable
- Outcomes of Differentiated Models of Antiretroviral Treatment (ART) ProvisionStatus unknownNCT03438370Not applicable
- Piloting At-birth Point of Care HIV Testing Strategies in KenyaCompletedNCT03435887Not applicable
- HIV Awal (Early) Testing & Treatment Indonesia Project Observational PhaseCompletedNCT03429842
- HIV Self-Testing to Empower Prevention Choices in Sex WorkersCompletedNCT03426670Not applicable
- Effect of High Dose Vitamin D Supplementation on HIV LatencyCompletedNCT03426592Phase 2
- Older HIV-infected Adults and Drug Interactions: French Cross-sectional StudyCompletedNCT03416881
- Prospective Clinical Trial of HIV+ Living Donor Kidney Donation for HIV+ RecipientsCompletedNCT03408106
- A Dose-Escalation Study of MDX-010 Administered Monthly as Immunotherapy in Subjects Infected With Human Immunodeficiency Virus (HIV)CompletedNCT03407105Phase 1
- Same-Day Treatment With Genvoya vs. EFV/TDF/3TCWithdrawnNCT03405194Not applicable
- Regional Bone Turnover Using 18F-fluoride-PET/CT in HIV-1-infected Men: PETRAM StudyStatus unknownNCT03405012
- Project Minority AIDS Prevention: Reaching Black and Hispanic MSM About PrEP and TasP Using Social MediaStatus unknownNCT03404531Not applicable
- Safety and Efficacy of Triptolide Wilfordii in New Onset HIV-1 InfectionCompletedNCT03403569Phase 3
- Real-world Insights of People With Human Immunodeficiency Virus (HIV) InfectionCompletedNCT03400293
- Study of Pentasa® for Reducing Residual Systemic Immune Activation in Treated HIV InfectionCompletedNCT03399903Phase 1/2
- Family-centered HIV Care, Viral Suppression and Retention in HIV-positive Children, SwazilandCompletedNCT03397420Not applicable
- Pharmacokinetic Study of Dapivirine Gel Administered Rectally to HIV-1 Seronegative AdultsCompletedNCT03393468Phase 1
- Infectious Diseases and Movement Program: Study of the Effects of Physical Activity on HIV InfectionStatus unknownNCT03392805Not applicable
- Evaluation of the Effect of Late Boost on HIV-uninfected Vaccines From EV06 TrialCompletedNCT03391375Phase 1
- Evaluation of the Population-level Impact of PMTCT Option B+ in ZimbabweCompletedNCT03388398
- Assessing Differential Adherence to Medications and Quality of Life Among People Living With HIV and ComorbiditiesCompletedNCT03387397
- Modifiers of Tenofovir in the Female Genital TractCompletedNCT03377608
- Costs, Efficiency and the Role of Management in HIV Prevention Interventions for Female Sex Workers in NigeriaTerminatedNCT03371914Not applicable
- Dual Therapy Etravirine + Raltegravir by Once Daily in HIV-positive Patients (ETRAL QD)CompletedNCT03369743
- Sofosbuvir and Daclatasvir for Treating Hepatitis C in 200 Patients Co-infected With Human Immunodeficiency VirusCompletedNCT03369327Phase 3
- Evaluation of Artemisia Annua and MoringaCompletedNCT03366922Not applicable
- Immediate Fast-Track Versus Standard Care for Persons Living With HIV in HaitiCompletedNCT03358927Not applicable
- The Intensified Treatment Monitoring Strategy to Prevent Accumulation of Drug Resistance (ITREMA) TrialCompletedNCT03357588Not applicable
- 30-to-90 Day Challenge: Effects of Alcohol Cessation on Health OutcomesCompletedNCT03353701Not applicable
- Reality Check: An HIV Risk Reduction Serial DramaCompletedNCT03352219Not applicable
- Optimizing the Efficiency and Implementation of Cash Transfers to Improve Adherence to Antiretroviral TherapyCompletedNCT03351556Not applicable
- Bitherapy With the Combination of Raltegravir and Darunavir (BIRDi)CompletedNCT03348449
- The Effects of Exercise Training in Vascular Function of Patients Living With HIVCompletedNCT03343522Not applicable
- Rural PrEP DeliveryCompletedNCT03343223Not applicable
- Effect of Dolutegravir on Etonogestrel Levels in HIV-infected Women in BotswanaCompletedNCT03336346
- Feasibility of Telerehabilitation in HIV-patientsCompletedNCT03335176Not applicable
- Identification of Broadly HIV-1 Neutralizing Antibodies (bNAb) in HIV-infected Patients in Mbeya, Tanzania.Active, not recruitingNCT03334552
- Reducing HIV Risk in Urban Women: Soap Opera Videos on Video-Capable Cell PhonesCompletedNCT03330522Not applicable
- PRJ2203: Dolutegravir Post Authorization Safety Study (PASS)CompletedNCT03327740
- Using HIV Risk Assessment Tool to Promote HIV Testing Among Men Who Have Sex With MenStatus unknownNCT03320239Not applicable
- Assessing the Impact of an Educational HIV Prevention Intervention in ZambiaCompletedNCT03316040Not applicable
- Revised Simplified Algorithm for Treatment Eligibility for HIV (SLATEII)CompletedNCT03315013Not applicable
- Phase 4 Study of Dolutegravir (DTG) in Russian FederationCompletedNCT03314064Phase 4